123 See, Inc.
Gaze-independent, contactless autorefractor technology for self-serve vision exam kiosks
- Sector
- Medtech
- Headquarters
- Wayland, MA
- Founded
- 2021
- Latest Form D
- $22M, Jul 2025
- Total capital
- $31.5M
- Federal grants
- $1.3M
- 2 awards · 2021–2023
- Rank in peer group#439 of 538
- Private capital raised
- $30.3M
- 2 Form D · last Jul 2025
- 15 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 5 pending · first 2025
- Rank in peer group#237 of 538
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$22M
- Private capital raisedForm D · SEC · 1st filing$8.3M
- Federal grantNSF · Phase II · SBIR Phase II:Gaze-independent contactless autorefractor for self-serve eye exam kiosk.$1M
- Federal grantNSF · Phase I · SBIR Phase I:Vision care station for on-demand rapid examination of visual performance.$276K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
29months
from 123 See, Inc.’s first federal award to its first private round.
- First federal award · Dec 2021
- NSF · $276K
- First Form D · May 2024
- $8.3M · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#237 · top 44%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- MATTHIAS HOFMANNResearcherExecutive Officer, DirectorLinked by 1 patent · $1.3M in grants as PI
- Axel BicharaDirectorNamed in SEC Form D filings
- CAITLIN DONOVANDirectorNamed in SEC Form D filings
- JACK MOLDAVEExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 6- GrantedBinocular Auto-lensmeterUSPTOUS 12,498,294
- PendingMethods And Apparatus For Ocular ExaminationUSPTOApplication 17971240
- PendingBinocular Auto-lensmeterUSPTOApplication PCTUS2023011436
Show all 6 patent records
- Binocular Auto-lensmeterDec 16, 2025 · US 12,498,294Granted
- Methods And Apparatus For Ocular ExaminationApr 27, 2023 · Application 17971240Pending
- Binocular Auto-lensmeterApplication PCTUS2023011436Pending
- Methods And Apparatus For Ocular ExaminationApplication PCTUS2022047459Pending
- Binocular Auto-lensmeterApplication 63302356Pending
- Methods And Apparatus For Ocular Aberration ExaminationApplication 63270907Pending
Related companies, and why
- TECHNOLOGY COMMERCIALIZATION PARTNERS, LLCSimilar federal contract value in Medtech · null in contracts
- IGE IMMUNODIAGNOSTICS & THERAPEUTICS, LLCSimilar federal contract value in Medtech · null in contracts
- GATEWAY PHARMACEUTICAL, LLCSimilar federal contract value in Medtech · null in contracts
- FLUID SYNCHRONY, LLCSimilar federal contract value in Medtech · null in contracts
- PULSETHERA CORPSimilar federal contract value in Medtech · null in contracts
- INNOGIZED TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .